Álvarez-López H, Díaz-Domínguez E

Idioma: Inglés [English version]
Referencias bibliográficas: 15
Paginas: s8-10
Archivo PDF: 130.86 Kb.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75 (6): 1334-1357.

2. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021-104.

3. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016; 134 (6): 441-450.

4. Organización Panamericana de la Salud. Hipertensión [Internet]. Washington D.C., USA.: 2023 [citado el 29 de junio de 2023]. Disponible en: https://www.paho.org/es/temas/hipertension

5. Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513-1518.

6. Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominic Zak AF et al. Hypertension. Nat Rev Dis Primers. 2018; 4: 18014.

7. WHO. Hypertension. World Heart Organization; 2023. Available in: https://www.who.int/news-room/fact-sheets/detail/hypertension

8. Campos-Nonato I, Hernández-Barrera L, Oviedo-Solís C, Ramírez-Villalobos D, Hernández-Prado B, Barquera S. Epidemiología de la hipertensión arterial en adultos mexicanos: diagnóstico, control y tendencias. Ensanut 2020. Salud Publica Mex. 2021; 63 (6): 692-704.

9. Ostchega Y, Fryar CD, Nwanko T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018. NCHS Data Brief, no 364. Hyattsville, MD: National Center for Health Statistics; 2020.

10. Ghazi L, Annabathula RV, Bello NA, Zhou L, Stacey RB, Upadhya B. Hypertension across a woman's life cycle. Curr Hypertens Rep. 2022; 24 (12): 723-733.

11. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398 (10304): 957-980.

12. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019; 105 (16): 1273-1278.

13. Elder P, Sharma G, Gulati M, Michos ED. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention. Am J Prev Cardiol. 2020; 2: 100028.

14. Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK et al. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75 (20): 2602-2618.

15. Wolf VL, Ryan MJ. Autoimmune disease-associated hypertension. Curr Hypertens Rep. 2019; 21 (1): 10.